愷英網絡(002517.SZ):騏飛投資8378.19萬股司拍股份4.03億元成交
格隆匯9月25日丨愷英網絡(002517.SZ)公佈,近日,上海金融法院在阿里拍賣平台上對股東騏飛投資所持有的8378.1948萬股公司股份進行第二次公開拍賣,該次拍賣已按期進行,於2020年9月24日10時起,因多次觸發延時出價功能,最終該次拍賣順延至2020年9月25日10時27分52秒止。
公告顯示,該次網絡拍賣競買人為嵊州嵊和企業管理合夥企業(有限合夥),成交股數為8378.1948萬股(佔公司總股本的3.89%);成交金額約為4.03億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.